Single-Photon Emission Computed Tomography Market

Global Single-Photon Emission Computed Tomography Market Summary:

According to Transpire Insights, a detailed research report on the market reflects that the cardiology application segment dominates the Global Single-Photon Emission Computed Tomography Market, accounting for approximately 22% of the total share worldwide. Siemens Healthineers AG leads the market with approximately (around USD 23 billion) in annual revenue and an estimated 18–22% global market share, making it the leading contributor to global market development, innovation, advanced SPECT imaging system production, expanding healthcare technology capabilities, and growth dynamics.

Market Snapshot

• Global Market Value (2025): USD 2.78 Billion.
• Expected Market Value (2026): USD 2.94 Billion.
• Estimated Market Value (2033): USD 4.37 Billion.
• Forecast CAGR (2026–2033): 5.83%.
• Leading Region in 2025: North America
• Second-largest Region: Europe
• Fastest Growing Region: Asia Pacific

Introduction

The production, distribution, and sales of nuclear imaging equipment and associated radiopharmaceuticals are all included in the SPECT market. These devices create precise 3D metabolic and functional imaging by combining specialized gamma cameras with radioactive tracers. Clinical applications in neurology, cardiology, and oncology are driving the market. Single-Photon Emission Computed Tomography (SPECT) is a sophisticated nuclear imaging method that produces intricate three-dimensional images of internal organ activity using radioactive tracers and a scanner. Medical practitioners can see blood flow, metabolism and cellular activity in real time by injecting a little quantity of a radiopharmaceutical into the bloodstream. Longer tracer half-lives compared to PET isotopes, SPECT isotopes (such as Tc-99m) have longer half-lives, which enable imaging to take place over several days to follow slow-diffusing molecules (such as peptides and antibodies). Capability for multiple trackers, two distinct radiotracers can be given and mapped simultaneously in a single scan thanks to SPECT's ability to gather photons of various energy independently. High affordability compared to PET or PET/CT systems, standalone SPECT systems are far less expensive to install and operate. Functional and anatomical mapping to lower false positives and boost diagnostic confidence, contemporary hybrid SPECT/CT systems combine metabolic data with accurate anatomical structures.

• For instance: The market for single-photon emission computed tomography (SPECT) is estimated to be worth $3.9 billion worldwide and is expected to expand at a compound annual growth rate (CAGR) of 5%–7%. Oncology and cardiology are the main causes. SaaS diagnostic systems and CZT (Cadmium-Zinc-Telluride) detector technologies are receiving more funding.

 Market Highlights: -

1. North America is expected to grow at a rapid CAGR in the Global Single-Photon Emission Computed Tomography Market by holding roughly40% of the share during the forecast period. 
2. Europe is anticipated to hold around 30% share of the Global Single-Photon Emission Computed Tomography Market over the predicted timeframe. 
3. Asia Pacific is anticipated to hold around 20% share of the Global Single-Photon Emission Computed Tomography Market over the predicted timeframe. 
4. By product type, the Hybrid SPECT/CT Systems segment dominated the market and holds roughly 62% share in 2025 and is projected to grow at a substantial CAGR during the forecast period. 
5. By application, the Cardiology segment dominated the market and holds roughly 22% share in 2025 and is projected to grow at a substantial CAGR during the forecast period. 
6. By end user, the Hospitals segment dominated the market and holds nearly 42% share in 2025 and is projected to grow at a substantial CAGR during the forecast period. 
7. Manufacturing & R&D (India): The PLI Scheme for Medical Devices and initiatives supporting the medical device industry promote domestic manufacturing and research of advanced diagnostic technologies. These programs help reduce import dependency, strengthen healthcare equipment production, and indirectly support the growth of SPECT imaging systems in India.

How is Technology Driving Growth in the GlobalSingle-Photon Emission Computed Tomography Market?

The introduction of hybrid SPECT/CT systems, CZT solid-state detectors, AI-driven image reconstruction, and cutting-edge radiopharmaceutical advances are driving major technological advancements in the global single-photon emission computed tomography (SPECT) market. By integrating functional and anatomical imaging, enhancing sensitivity, lowering radiation exposure, and boosting workflow efficiency, these technologies improve diagnostic accuracy. While innovative radiotracers offer personalized medical applications in neurology, cardiology, and oncology, AI integration allows automated analysis and high-quality image production. Nuclear imaging technologies' ongoing development is boosting clinical capabilities, increasing healthcare use, and quickening global market expansion.

Market Drivers

Growing burden of chronic illnesses advanced functional imaging is required for early diagnosis and therapy planning due to the rising incidence of cancer and cardiovascular disorders worldwide. Aging geriatric population the need for routine diagnostic imaging is growing quickly since people over 60 are more prone to long-term neurological and cardiovascular disorders. Technological developments digital CZT (Cadmium-Zinc-Telluride) detectors and hybrid SPECT/CT systems offer faster scan times and improved resolution. Increased radiopharmaceutical development advances in precision "theranostics" and targeted radioisotopes (like Technetium-99m and Gallium-67) are increasing clinical capabilities. Institutional infrastructure upgrades, modern nuclear medicine facilities are being established by hospitals and diagnostic centers thanks to increased government financing and healthcare investments in developing regions. Physiological insights SPECT shows how organs function, as opposed to traditional imaging, which just shows organ structure (e.g., mapping blood flow to the heart or brain activity).Hybrid Imaging (SPECT/CT) diagnostic precision, illness staging, and treatment planning are greatly enhanced by combining the functional sensitivity of nuclear medicine with the accurate structural mapping of CT. Cost-effectiveness SPECT is more accessible and economical for hospitals than PET (Positron Emission Tomography) because it uses radiotracers that are more commonly available and have a longer half-life, such as Technetium-99m. Advanced technology integration of digital CZT (Cadmium-Zinc-Telluride) detectors and AI-enabled reconstruction, which enhance image resolution while reducing radiation doses, are driving the industry.

• For instance: - While focused investments are being made in improved CT hardware in South Africa, the nuclear medicine business, which includes SPECT, is still hindered by high equipment costs, costly imports of radiopharmaceuticals, and restricted access in public healthcare.
• The global SPECT market is estimated to be about $3.5–$4 billion and is expanding at an annual pace of 2.78% to 6.69%. Because of its well-established healthcare system, significant investments in precision medicine, and extensive use in cardiology and cancer, the United States continues to be the leading regional market with the biggest revenue share (almost 41%).

Restrain

High equipment prices, limited availability of radiopharmaceuticals, competition from PET/CT technologies, short isotope half-lives, and strict regulations are some of the issues facing the global single-photon emission computed tomography (SPECT) market. These elements restrict uptake and raise operational complexity, especially in developing healthcare markets.

Analysis of Prices and Consumer Behaviour 

The Hybrid SPECT/CT Systems dominate the sales of Single-Photon Emission Computed Tomography (SPECT). This accounts for 62% of the market size, in part driven by demand from hospitals and diagnostic imaging centers, and nuclear medicine departments. Prices of hybrid SPECT/CT are higher than that of the traditional SPECT since they combine advanced CT technology, high-quality detectors, AI reconstruction tools, and superior imaging skills. At present, hybrid SPECT/CT comprise about 45% percent of SPECT installations worldwide. The growing sales of hybrid SPECT/CT systems can be attributed to better anatomical and functional imaging, improved identification of diseases, and steadily widening range of applications in oncology and cardiology. The cardiology and oncology field makes up about 65% of the entire demand for SPECT, partly due to the increasing rates of cardiovascular diseases and the expanding necessity of cancer diagnostics. According to the purchasing behavior of healthcare organizations, 55% of customers pay great attention to diagnostic accuracy, image quality, reliability, and hi-tech features. Moreover, about 33% of healthcare organizations are interested in signing long-term purchase agreements or contracts for services to reduce their operating costs and guarantee access to advanced nuclear imaging technology on a continuous basis.

Top Companies in the GlobalSingle-Photon Emission Computed Tomography Market

1. GE HealthCare
2. Siemens Healthineers
3. Philips Healthcare
4. Canon Medical Systems
5. Spectrum Dynamics Medical
6. Mediso
7. Digirad
8. DDD-Diagnostic
9. Shimadzu Corporation
10. United Imaging Healthcare
11. Neusoft Medical Systems
12. Fujifilm Healthcare
13. Samsung Medison
14. SurgicEye
15. Bracco Imaging

Market Segmentation

The Global Single-Photon Emission Computed Tomography Market share is divided into five categories: By product type, application, end user, detector type and distribution channel.

The Hybrid SPECT/CT Systems dominated the market, accounting for roughly 62% in 2025 and is expected to rise at a significant CAGR during the forecast period.

The Global Single-Photon Emission Computed Tomography Market is segmented by product type into Standalone SPECT Systems, Hybrid SPECT/CT Systems, Cardiac SPECT Systems, Brain SPECT Systems, Mobile SPECT Systems, Digital SPECT Systems, AI-assisted Imaging Systems, Others. Among these, the Hybrid SPECT/CT Systems segment dominated the market, accounting for roughly 62% in 2025 and expected to increase at a significant CAGR during the forecast period. Due to their superior diagnostic accuracy, combined functional and anatomical imaging capabilities, improved disease detection, growing adoption in cardiology and oncology, technological advancements, and rising demand for advanced nuclear medicine solutions, hybrid SPECT/CT systems dominated the global single-photon emission computed tomography (SPECT) market, holding a roughly 62% share in 2025.

The Cardiology dominated the market, accounting for roughly 22% in 2025, and is expected to rise at a significant CAGR during the forecast period.

The Global Single-Photon Emission Computed Tomography Market is segmented by application into Cardiology, Oncology, Neurology, Orthopedics, Endocrinology, Research, Others. Among these, the BFSI Cardiology segment dominated the market, accounting for roughly 22% in 2025 and expected to increase at a significant CAGR during the forecast period. This was due to a number of factors, including the growing prevalence of cardiovascular diseases, the growing demand for accurate cardiac imaging, the growing use of nuclear cardiology procedures, improved diagnostic capabilities, technological advancements, and the expansion of healthcare infrastructure worldwide.

The Hospitals dominated the market, accounting for nearly 42% in 2025 and is expected to rise at a significant CAGR during the forecast period.

The Global Single-Photon Emission Computed Tomography Market is segmented by end user into Hospitals, Diagnostic Imaging Centers, Academic Institutes, Specialty Clinics, Research Centers, Others. Among these, the Hospitals segment dominated the market, accounting for nearly 42% in 2025 and expected to increase at a significant CAGR during the forecast period. Due to growing patient admissions, increased demand for advanced diagnostic imaging, the availability of specialized nuclear medicine departments, an increase in cardiovascular and oncology cases, technological advancements, and increased investments in healthcare infrastructure, the hospitals segment dominated the global single-photon emission computed tomography (SPECT) market, holding nearly 42% of the market in 2025.

Regional Segment Analysis of the Global Single-Photon Emission Computed Tomography Market:

• North America (U.S., Canada, Mexico)  
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe) 
• Asia-Pacific (China, Japan, India, Rest of APAC) 
• South America (Brazil and the Rest of South America)  
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is the fastest-growing region in the Global Single-Photon Emission Computed Tomography Market during the period, holding roughly 40% share.

North America is expected to grow at a rapid CAGR in the Global Single-Photon Emission Computed Tomography Market holding roughly 40% share during the forecast period. This is due to a number of factors, including the region's advanced healthcare infrastructure, rising rates of neurological and cardiovascular disorders, growing use of nuclear medicine imaging, robust research investments, technological advancements, favorable reimbursement policies, and the presence of top diagnostic imaging companies.

Europe is expected to grow at a rapid CAGR in the Global Single-Photon Emission Computed Tomography Market, holding around 30% of the share during the forecast period

Europe is expected to grow at a rapid CAGR in the Global Single-Photon Emission Computed Tomography Market holding around 30% share during the forecast period. In the global single-photon emission computed tomography (SPECT) market, Europe is predicted to grow at a rapid compound annual growth rate (CAGR) and hold around 30% of the market during the forecast period. This growth will be fueled by advanced healthcare infrastructure, growing nuclear imaging technology adoption, rising chronic disease prevalence, government healthcare investments, research advancements, and a strong presence of top medical imaging manufacturers.

Asia Pacific is the fastest-growing region in the Global Single-Photon Emission Computed Tomography Market during the period, holding around 20% share.

Asia Pacific is the fastest-growing region in the Global Single-Photon Emission Computed Tomography Market during the forecast period, holding around 20% share during the forecast period. This is due to a number of factors, including growing healthcare infrastructure, an increase in the prevalence of cancer and cardiovascular diseases, rising healthcare spending, an increase in the use of advanced diagnostic imaging technologies, government healthcare initiatives, and rising investments in nuclear medicine facilities across emerging economies.

Strategies for Market Growth in Non-Leading Regions:

The advancement of non-primary territories with the usage of effective and abundant SPECT technologies will help small and medium-sized businesses engaged in healthcare supplies. The implementation of production facilities near companies will enable further medical imaging development and to address the issue of dependency on imports, which will lead to reduced expenditures on equipment and its maintenance. Creating partnerships with hospitals, diagnostic institutions, research institutions, and medical equipment distribution companies will contribute to the penetration into SPECT markets. The increase of knowledge regarding the operation of SPECT, nuclear medicine practices, system maintenance, and modern imaging methods will require provision of training and improvement of technical skills. Besides, different financing variants, long-term service contracts, and equipment leasing programs will make SPECT technologies more affordable.

Future Market Trends for the GlobalSingle-Photon Emission Computed Tomography Market: -

1. Growth of Hybrid SPECT/CT Systems: The main growth factor is the combination of anatomical CT and functional SPECT. Hybrid systems reduce the need for several scans by providing accurate assessment of cardiovascular disorders and enhanced staging for oncology.
2. CZT Detector Technology Adoption: By increasing photon conversion efficiency by roughly 30%, cadmium zinc telluride (CZT) detectors are transforming the market. This results in much faster scan times, improved spatial resolution, and quantitative imaging capabilities.
3. Artificial Intelligence (AI) Integration: Deep learning models and AI algorithms are being used more and more for automated workflow optimization, noise reduction, and picture reconstruction. As a result, radiologists have less work to do and are more confident in their diagnosis.
4. Transition to Theranostics: The clinical relevance of SPECT in customized cancer treatment is growing due to the development of theranostics, which uses the same molecular foundation for both targeted radionuclide therapy and diagnosis.
5. Asia-Pacific Regional Growth: Although North America has the highest revenue share, the Asia-Pacific area is growing at the fastest rate because of growing diagnostic networks in nations like India, more patient awareness, and quick investments in healthcare infrastructure.

Recent Development

• In April 2026: Amrita Hospital Installs Siemens Symbia Pro.specta SPECT/CT System: Amrita Hospital, Kochi, India, inaugurated the advanced Siemens Symbia Pro.specta SPECT/CT system, incorporating intelligent imaging technologies and workflow optimization capabilities. The system enhances oncology, cardiology, and neurology diagnostics by improving image quality, reducing scan duration, increasing operational efficiency, and supporting advanced nuclear medicine applications.
• In March 2026: AI-Integrated SPECT/CT Software Advancements leading medical imaging manufacturers, including GE HealthCare and Siemens Healthineers, advanced AI-powered SPECT/CT software solutions through deep-learning image reconstruction, automated workflow optimization, and data-driven diagnostic technologies. These innovations enhance image quality, improve diagnostic accuracy, reduce radiation exposure, and support efficient precision imaging applications in nuclear medicine.
• In January 2026: CMS Initiatives Supporting Mo-99 Supply Security the Centers for Medicare & Medicaid Services (CMS) introduced initiatives focused on strengthening the domestic supply chain for Molybdenum-99 (Mo-99), supporting the availability of Technetium-99m (Tc-99m) radiotracers used in SPECT imaging. These measures enhance supply reliability, improve nuclear medicine workflow continuity, and support the adoption of advanced SPECT technologies in healthcare facilities.

This study forecasts revenue at global, regional and country levels from 2020 to 2033. Transpire Insights has segmented the Global Single-Photon Emission Computed Tomography Market based on the below-mentioned segments:

Global Single-Photon Emission Computed Tomography Market, By Product Type

• Standalone SPECT Systems
• Hybrid SPECT/CT Systems
• Cardiac SPECT Systems
• Brain SPECT Systems
• Mobile SPECT Systems
• Digital SPECT Systems
• AI-assisted Imaging Systems
• Others

Global Single-Photon Emission Computed Tomography Market, By Application

• Cardiology
• Oncology
• Neurology
• Orthopedics
• Endocrinology
• Research
• Others

Global Single-Photon Emission Computed Tomography Market, By End User

• Hospitals
• Diagnostic Imaging Centers
• Academic Institutes
• Specialty Clinics
• Research Centers
• Others

Global Single-Photon Emission Computed Tomography Market, By Detector Type

• Sodium Iodide Detectors
• CZT Detectors
• Solid-state Detectors
• Hybrid Detectors
• Others

Global Single-Photon Emission Computed Tomography Market, By Distribution Channel

• Direct Sales
• Medical Equipment Distributors
• Hospital Procurement
• Others

Global Single-Photon Emission Computed Tomography Market, By Regional Analysis

North America

• United States
• Canada
• Mexico

Europe

• Germany
• United Kingdom
• France
• Italy 
• Spain
• Russia
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• South Korea
• Australia
• Rest of Asia Pacific

South America

• Brazil
• Argentina
• Rest of South America

Middle East & Africa

• Saudi Arabia
• United Arab Emirates
• Qatar 
• South Africa
• Rest of the Middle East & Africa